Efficacy and Safety of Grazoprevir (MK-5172), Elbasvir (MK-8742), and Sofosbuvir for Chronic Infection With Hepatitis C Virus Genotypes 1 and 3 (MK-5172-074)
Clinical trial NCT02133131 · COMPLETED
Trial details
- NCT number
- NCT02133131
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-13
- Primary completion
- 2015-11-02
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.